A crash has closed part of a major Las Vegas freeway near Spring Mountain Road in the central valley, according to Nevada ...
The Federal Communications Commission said on Friday it has approved SpaceX's request to deploy another 7,500 ...
Times Herald-Record on MSN
College men's basketball: TV, radio, web schedules for 2025-26 season
The 2025-26 college men's basketball season gets underway on November 3, 2025, and concludes in April with postseason action. All the major networks - ABC, CBS, NBC, Fox, The CW - will ...
Clark County Commissioners are set to vote on a proposal to add a $1 surcharge for landlines and wireless phone numbers to ...
9-1-1: Nashville Season 9, Episode 7 will premiere on Thursday, January 8, 2026 in its typical time slot. Tune in to ABC at 9:00 p.m. ET. Like 9-1-1 Season 9, 9-1-1: Nashville ‘s debut season will ...
A six-episode, behind-the-scenes Disney+ docuseries about Taylor Swift's Eras Tour and Rian Johnson's third "Knives Out" movie, "Wake Up Dead Man," are some of the new television, films, music and ...
Flight attendant preparation might be more complicated than you think. Their training programs involve safety, aircraft knowledge, customer service, medical and emergency procedures – not to mention ...
Halda Therapeutics researchers at work in the company’s lab. Johnson & Johnson has agreed to acquire Halda for $3.05 billion cash, the companies said today, in a deal designed to expand the buyer’s ...
Johnson & Johnson (JNJ) has announced its plan to purchase Halda Therapeutics, a firm focused on developing oral therapies aimed at treating various solid tumors, for $3.05B in cash. The company ...
(RTTNews) - Johnson & Johnson (JNJ) announced Monday that it has entered into a definitive agreement to acquire biotechnology company Halda Therapeutics OpCo, Inc. for $3.05 billion in cash. Halda is ...
Acquisition provides highly differentiated clinical-stage treatment for prostate cancer, building on Johnson & Johnson’s nearly two decades of innovation in the disease area Lead asset shows potential ...
Johnson & Johnson (NYSE: JNJ) on Monday agreed to acquire Halda Therapeutics OpCo, Inc. for $3.05 billion in cash. Halda is a clinical-stage biotechnology company with a proprietary Regulated Induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results